MIT-Ivy Industry ne a Pharmaceutical da kuma sinadaran tsaka-tsaki sha'anin hadawa samar, tallace-tallace da kuma kimiyya research.With da ci-gaba samar da kayan aiki da kuma samar da fasaha, mu kula da kyau hadin gwiwa dangantaka da kimiyya cibiyoyin bincike da kuma manyan da kuma matsakaici jami'o'i.Mun fi tsunduma a cikin samarwa da tallace-tallace na jerin magunguna masu tsaka-tsaki, musamman ma a cikin maganin cutar kanjamau, cututtukan zuciya da na cerebrovascular, da kuma goyon bayan tsaka-tsakin magungunan anti-mai kumburi. Samfuran sodium azide, triphenyl chloromethane, L. Ana sayar da valine methyl ester hydrochloride a gida da waje.1.Gabatarwar Matsakaicin Magungunan Magunguna Matsakaicin Matsakaicin Magunguna suna komawa ga samfuran tsaka-tsaki kamar albarkatun ƙasa, kayan aiki da abubuwan haɓaka waɗanda aka yi amfani da su wajen samar da samfuran magunguna.A gaskiya ma, wasu nau'ikan albarkatun sinadarai ne ko samfuran sinadarai a cikin tsarin hada magunguna. kuma abubuwa masu aiki na miyagun ƙwayoyi suna buƙatar karɓar takaddun shaida na GMP.Matsakaicin magunguna, ko da yake ana amfani da su wajen samar da magunguna, ainihin ƙira ne kawai da samar da albarkatun sinadarai.Su ne mafi mahimmanci da samfurori na ƙasa a cikin sarkar samar da miyagun ƙwayoyi kuma ba za a iya kiran su da kwayoyi ba, don haka ba a buƙatar takardar shaidar GMP. Ana iya samar da magungunan magunguna a cikin tsire-tsire masu sinadarai na yau da kullum kuma za'a iya amfani da su a cikin haɗuwa da samfurori na magani a wasu matakan. Hakanan yana rage ƙofar shiga masana'antar don masana'antun matsakaici. Hoton2.Matsakaicin matsakaicin masana'antar harhada magunguna Tare da daidaita tsarin masana'antu, canja wurin samar da kayayyaki zuwa kasashen ketare, da kara inganta sashen ma'aikata na kasa da kasa na manyan kamfanonin harhada magunguna na kasa da kasa, kasar Sin ta zama muhimmin tushe na samar da magunguna a bangaren hada-hadar harhada magunguna ta duniya.A cewar bincike. Rahoton da aka yi kan bunkasuwar masana'antar hada magunguna ta kasar Sin (2016), daga shekarar 2011 zuwa 2015, masana'antun sarrafa magunguna na kasar Sin da jimillar adadin kayayyakin da suke fitarwa ya karu a kowace shekara, inda adadin karuwar da ake samu a duk shekara ya kai kusan kashi 13.5%. Ma'aikatar harhada magunguna ta kasar Sin ta kai yuan biliyan 422.56 a shekarar 2015, adadin da ya karu da kashi 9.88 bisa dari a shekara, yawan masana'antu ya kai tan miliyan 17.2, wanda ya karu da kashi 10.26 cikin dari a shekara. yuan nan da 2020. Hoton3.Halayen masana'antu na tsaka-tsakin harhada magunguna Masana'antu suna buƙatar haɓakawa da haɓaka cikin gaggawa: Gabaɗaya matakin fasaha na kasar Sin har yanzu yana da ƙasa kaɗan, kuma akwai ƙananan masana'antun da ke samar da adadi mai yawa na ci-gaba na magunguna da kuma tallafawa masu tsaka-tsakin sabbin magunguna, waɗanda ke cikin ci gaba. mataki na samfurin tsarin ingantawa da kuma upgrading.Only wasu Enterprises da karfi da bincike da kuma ci gaban ƙarfi, ci-gaba samar da wurare da kuma manyan-sikelin samar da kwarewa iya samun high riba a cikin gasar.Stable kasuwanci sikelin: Manyan-sikelin masana'antun m dauki musamman samar a matsayin su main tsarin kasuwanci.A ƙarƙashin ƙirar samarwa da aka keɓance, haɗin gwiwar haɗin gwiwa tsakanin manyan abokan ciniki da masu samar da kayayyaki yana da ɗan kwanciyar hankali, kuma kusancin haɗin gwiwa, mafi girman matakin amincewa, da ƙarin nau'ikan haɗin gwiwar da manyan abokan ciniki ke bayarwa zai zama.Yana ɗaukar lokaci mai tsawo don canzawa. masu kawo kaya.Saboda haka, a matsayin kasuwanci da karfi stickiness, Pharmaceutical intermediates masana'antu Enterprises yafi mayar da hankali a kan sanannun kasashen waje Pharmaceutical Enterprises a halin yanzu mataki.Da zarar kamfanin ya shiga cikin core maroki tsarin na Pharmaceutical Kattai, da samar da sikelin da kuma babban riba gefe kiyaye wani. fairly barga state.Low-karshen fitarwa yafi: babban fitarwa yankuna na Pharmaceutical intermediates a kasar Sin su ne EU, Arewacin Amirka, Gabas ta Tsakiya, kudu maso gabashin Asiya, da dai sauransu.The fitarwa na kasar mu yafi mayar da hankali a bitamin C, penicillin, acetaminophen, citric acid. da gishiri da esters, irin su kayayyaki, halayen samfuran shine samar da kayayyaki, masana'antar samarwa, gasar kasuwa tana da ƙarfi, farashin samfur da ƙarin ƙimar ya yi ƙasa, yawan samar da su ya haifar da hauhawar farashin kayayyaki na cikin gida. Har yanzu ana shigo da kayayyakin fasaha na zamani.Kananan masana'antu da matsakaita: the production enterprYawancin kamfanoni masu zaman kansu ne, masu sassaucin ra'ayi, sikelin saka hannun jari ba shi da girma, a tsakanin miliyoyin zuwa yuan miliyan goma ko ashirin. Tattalin arzikin yanki: rabon ayyukan da ake samarwa a yankin ya fi mayar da hankali sosai, a kusa da manyan masana'antar harhada magunguna, galibi ana rarraba su a Taizhou, Zhejiang da Jintan, Jiangsu a matsayin cibiyar yankin.Zhejiang Huangyan, Taizhou, Nanjing Jintan, Shijiazhuang, Jinan (ciki har da Zibo), arewa maso gabas (Siping, Fushun) da sauran yankunan da ke da yanayi mai kyau na ci gaban masana'antar harhada magunguna sun bunkasa musamman cikin sauri. Saurin sabunta samfur: samfurin gabaɗaya yana kan kasuwa bayan shekaru 3 zuwa 5, ƙimar ribarsa za ta ragu sosai, wanda ke tilasta wa kamfanoni su ci gaba da haɓaka sabbin kayayyaki ko kuma inganta tsarin samarwa koyaushe, don ci gaba da samun riba mai girma. : saboda ribar samar da magunguna masu tsaka-tsaki ya fi wannan of kayayyakin sinadarai, kuma tsarin samar da su guda biyu iri daya ne, da yawan kananan masana'antun sinadarai suna shiga samar da magunguna masu tsaka-tsaki, wanda ke haifar da gasa mai tsanani a cikin masana'antu.4.Nau'o'in magungunan magungunaAkwai nau'o'in magunguna masu yawa, ciki har da cephalosporin intermediates, amino acid protectant series, vitamin intermediates, quinolone intermediates, da sauran nau'o'in tsaka-tsaki, irin su magungunan magungunan likita, magungunan maganin cututtuka, masu tsaka-tsakin magungunan antiepileptic, masu tsaka-tsakin fluoropyridine, masu tsaka-tsakin steroid, da dai sauransu. Dangane da filayen aikace-aikacen su, ana iya rarraba su zuwa tsaka-tsaki na magungunan ƙwayoyin cuta, magungunan antipyretic da analgesic, masu tsaka-tsaki na tsarin zuciya da jijiyoyin jini, tsaka-tsakin magungunan ciwon daji da sauransu. innovate, forming da yawa lafiya kwayoyin masana'antu a cikin Pharmaceutical intermediates masana'antu.There akwai da yawa iri takamaiman Pharmaceutical intermediates.Kamar imidazole, furan, phenolic intermediates, aromatic intermediates, pyrrole, pyridine, biochemical reagents, sulfur, nitrogen, halogen mahadi, heterocyclic mahadi, microcrystalline cellulose, sitaci, mannitol, lactose, dextrin, ethylene glycol, powdered sugar, inorganic salts, ethanol intermediates, stearic acid, amino acid da ethanol amine gishiri, sylvite, sodium gishiri da sauran tsaka-tsaki da sauransu. Hoton 5.Patent CliffTun daga 2000, kasuwar jigilar kayayyaki ta duniya ta ci gaba da girma cikin sauri fiye da kasuwar magunguna gabaɗaya, tana haɓaka fiye da sau biyu cikin sauri kamar yadda aka ƙirƙira. Ana sa ran kasuwar magunguna daga 2005 zuwa 2013 za ta kai 14.7%. Ana sa ran kasuwar jigilar kayayyaki ta duniya za ta yi girma da kashi 10% zuwa 14% a cikin shekaru biyar masu zuwa, da sauri fiye da yadda ake tsammanin ci gaban 4% zuwa 6% ga dukkan masana'antar harhada magunguna. Ana iya fahimtar cewa ci gaban kasuwar magunguna a bayyane zai inganta ci gaban masana'antar magunguna ta tsakiya. Daga 2010 zuwa 2020, kasuwar harhada magunguna ta duniya za ta haifar da tashin hankali na karewa na Patent, daga cikinsu, daga 2013 zuwa 2020. nau'in ƙarewar ikon mallaka na duniya za su wuce fiye da 200 a kowace shekara, wanda aka sani da "Patent Cliff" a duniya. A cikin 2014, za a sami kololuwar karewa na miyagun ƙwayoyi, inda za a sami p.eak a cikin 2014, tare da jimillar magungunan haƙƙin mallaka 326 suna ƙarewa.2010 da 2017 sune shekaru biyu na dangi kololuwa, tare da 205 da 242 magungunan haƙƙin mallaka suna ƙarewa bi da bi.Magungunan da suka ƙare sun fi kashe ƙwayoyin cuta, endocrine, tsarin juyayi da magungunan zuciya na zuciya, tare da girman kasuwa mai girma. Yawan ƙarewar magungunan haƙƙin mallaka na ƙasashen waje zai kawo sabbin abubuwan haɓaka masana'antar magunguna a China.Saboda bayan ƙarewar haƙƙin mallaka. kwayoyi, samar da magungunan da ke da alaƙa za su fashe, wanda zai haifar da saurin haɓakar buƙatun magunguna masu alaƙa. Hoton6.Matsalolin muhalli China ta riga ta zama babban mai fitar da matsakaicin API, da kuma babban mai gurbata muhalli.Masu kera magunguna na cikin masana'antar sinadarai masu kyau, za a sami haɗarin gurɓataccen gurɓataccen yanayi.A cewar kididdigar da Ma'aikatar Kare Muhalli ta yi, jimillar ƙimar fitarwa na Masana'antar harhada magunguna ta cikin gida ba ta kai kashi 3 cikin 100 na GDP na kasar ba, amma jimillar gurbatar yanayi ya kai kashi 6. Daga cikin dukkan nau'ikan magunguna, API da aka fi wakilta da bitamin da penicillin na cikin masana'antar gurbatar yanayi da yawan amfani da makamashi. wanda ke gurɓata iska da ruwa musamman da gaske.A bisa ga haɗin kai na ma'aikatar kare muhalli, a ranar 15 ga Fabrairu, 2017, ƙungiyar sa ido ta musamman don ingancin iska a cikin kwata na farko na 2017 ya sanar da cewa ba a gudanar da matsin lamba a Shijiazhuang ba. a wurin, kuma har yanzu gwamnatin matakin gundumomi ta dogara ne akan Muhallil Kare Ofishin ma'aikata a cikin aiwatar da babban gurbataccen yanayi gaggawa shirin, yayin da sauran sassan ba su da hannu a cikin wani babban mataki.The gurbatawa na kanana da matsakaita-sized Enterprises samar Pharmaceutical intermediates a Shijiazhuang ne serious.Pharmaceutical Enterprises tare da baya da fasaha za su kai. high gurbatawa kula da halin kaka da ka'idoji matsa lamba, da kuma gargajiya Pharmaceutical Enterprises, yafi samar da high gurbatawa, high amfani da makamashi da kuma low darajar-kara kayayyakin (kamar penicillin, bitamin, da dai sauransu) za su fuskanci accelerated elimination.Adhering zuwa aiwatar da bidi'a da kuma bunkasa kore Pharmaceutical fasahar. ya zama jagorar ci gaba na gaba na masana'antar matsakaicin magunguna. Hoton
7. Shugabannin masana'antu
masana'antar mit-ivy
Zhejiang NHU Company Ltd. Plo Co., Ltd
Lianhe Chemical Technology Co., Ltd.Anhui Bayi Chemical Co. Ltd.Zhejiang Huahai Pharmaceutical Co. Ltd.Zhejiang Hisoar Pharmaceutical Co., Ltd.Jiangsu Jiujiu Technology Co., Ltd.Federal pharmaceutical (chengdu) co., LTDZhejiang Yongtai Technology Co., Ltd. Specialty Chemicals Co., Ltd.